Summary:
A study assessing the effectiveness of an investigational medication for the acute treatment of migraine.
Qualified Participants Must:
Be 18-65 years of age, inclusive
Have a diagnosis of migraine for at least 1 year
Qualified Participants May Receive:
- Reimbursement for time and travel
- Study-related care and study medicine at no cost (no health insurance required)